141 related articles for article (PubMed ID: 17477938)
1. Tissue distribution of humanized anti-human Fas monoclonal antibody (R-125224) based on fas antigen-antibody reaction in collagen-induced arthritis monkeys.
Saito M; Yoshigae Y; Nakayama J; Ogawa Y; Ohtsuki M; Kurihara A; Ikeda T
Life Sci; 2007 May; 80(22):2005-14. PubMed ID: 17477938
[TBL] [Abstract][Full Text] [Related]
2. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
[TBL] [Abstract][Full Text] [Related]
3. Highly frequent anti-idiotype antibody in cynomolgus monkeys developed against mouse-derived regions of anti-Fas antibody humanized by complementarity determining region grafting.
Saito-Yabe M; Yoshigae Y; Takasaki W; Kurihara A; Ikeda T; Okazaki O
Br J Pharmacol; 2009 Sep; 158(2):548-57. PubMed ID: 19645714
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.
Lin YS; Nguyen C; Mendoza JL; Escandon E; Fei D; Meng YG; Modi NB
J Pharmacol Exp Ther; 1999 Jan; 288(1):371-8. PubMed ID: 9862791
[TBL] [Abstract][Full Text] [Related]
5. A humanized anti-human Fas antibody, R-125224, induces apoptosis in type I activated lymphocytes but not in type II cells.
Nakayama J; Ogawa Y; Yoshigae Y; Onozawa Y; Yonemura A; Saito M; Ichikawa K; Yamoto T; Komai T; Tatsuta T; Ohtsuki M
Int Immunol; 2006 Jan; 18(1):113-24. PubMed ID: 16361317
[TBL] [Abstract][Full Text] [Related]
6. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells.
Ogawa Y; Ohtsuki M; Uzuki M; Sawai T; Onozawa Y; Nakayama J; Yonemura A; Kimura T; Matsuno H
Arthritis Rheum; 2003 Dec; 48(12):3350-8. PubMed ID: 14673986
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody.
Yamamoto N; Nakashima T; Torikai M; Naruse T; Morimoto J; Kon S; Sakai F; Uede T
Int Immunopharmacol; 2007 Nov; 7(11):1460-70. PubMed ID: 17761350
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
[TBL] [Abstract][Full Text] [Related]
9. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 reduces the severity of collagen-induced arthritis.
Tanaka K; Horikawa T; Suzuki S; Kitaura K; Watanabe J; Gotoh A; Shiobara N; Itoh T; Yamane S; Suzuki R; Fukui N; Ochi T
J Rheumatol; 2008 Dec; 35(12):2316-24. PubMed ID: 19004048
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic antibody targeting of CD97 in experimental arthritis: the role of antigen expression, shedding, and internalization on the pharmacokinetics of anti-CD97 monoclonal antibody 1B2.
de Groot DM; Vogel G; Dulos J; Teeuwen L; Stebbins K; Hamann J; Owens BM; van Eenennaam H; Bos E; Boots AM
J Immunol; 2009 Sep; 183(6):4127-34. PubMed ID: 19717518
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of humanized monoclonal antibody rhuMAb2H7 in cynomolgus monkey serum using a Generic Immunoglobulin Pharmacokinetic (GRIP) assay.
Yang J; Ng C; Lowman H; Chestnut R; Schofield C; Sandlund B; Ernst J; Bennett G; Quarmby V
J Immunol Methods; 2008 Jun; 335(1-2):8-20. PubMed ID: 18402977
[TBL] [Abstract][Full Text] [Related]
15. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
16. C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice.
Blom AM; Nandakumar KS; Holmdahl R
Ann Rheum Dis; 2009 Jan; 68(1):136-42. PubMed ID: 18276745
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys.
Suzuki T; Muraki Y; Yasukochi T; Zhang H; Kori Y; Wakamatsu E; Hayashi T; Goto D; Ito S; Tsutsumi A; Sumichika H; Sumida T; Matsumoto I
Autoimmun Rev; 2005 Sep; 4(7):475-8. PubMed ID: 16137614
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
Stubenrauch K; Wessels U; Lenz H
J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
[TBL] [Abstract][Full Text] [Related]
19. In SCID mice with transplanted joint tissues from rheumatism patients, a model mice of human rheumatoid arthritis, anti-human fas antibody (R-125224) distributes specifically to human synovium.
Saito M; Yoshigae Y; Nakayama J; Ogawa Y; Ohtsuki M; Kurihara A; Ikeda T
Pharm Res; 2007 Feb; 24(2):310-7. PubMed ID: 17180729
[TBL] [Abstract][Full Text] [Related]
20. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
Davis CB; Garver EM; Kwok DC; Urbanski JJ
Drug Metab Dispos; 1996 Sep; 24(9):1032-7. PubMed ID: 8886616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
